by Vandana Singh | Mar 31, 2026 | General
Novo Nordisk A/S (NYSE:NVO) on Tuesday introduced a multi-month subscription program for its obesity treatment Wegovy (semaglutide), aiming to make pricing more predictable for self-pay patients and improve long-term adherence. Earlier in March, the U.S. Food and Drug...
by Chandrima Sanyal | Mar 31, 2026 | General
The specter of political interference in the Federal Reserve is rippling through the market, and for ETF investors, the parallels to the 1970s are becoming more and more difficult to ignore. • What’s next for TIP stock? While Sen. Elizabeth Warren has accused...
by Nabaparna Bhattacharya | Mar 31, 2026 | General
The U.K.’s Competition and Markets Authority said Tuesday it will launch a strategic market status (SMS) investigation into Microsoft Corporation’s (NASDAQ:MSFT) business software ecosystem, as part of a broader push to increase competition in cloud services and...
by Evette Mitkov | Mar 31, 2026 | General
Dell Technologies Inc (NYSE:DELL) shares slid on Tuesday after a new analyst initiation cast the stock in a more cautious light, handing the company a Hold rating. Here’s what you should know today. Dell Technologies stock is feeling bearish pressure. Why is DELL...
by Vandana Singh | Mar 31, 2026 | General
William Blair upgraded 10x Genomics Inc. (NASDAQ:TXG) stock, citing it as the best-in-class technology and is well-positioned to benefit from recovering end-markets and emerging demand for large-scale biological datasets to train AI models. • 10x Genomics shares are...
Recent Comments